Use of pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) via point-of-care (POC) troponin measurement by ambulance staff resulted in significant reductions in healthcare costs with no difference in adverse events, new Dutch trial data suggest.